Potential new therapeutic agents for diabetic kidney disease.

  title={Potential new therapeutic agents for diabetic kidney disease.},
  author={Faruk Hilmi Turgut and Warren K Bolton},
  journal={American journal of kidney diseases : the official journal of the National Kidney Foundation},
  volume={55 5},
Diabetic nephropathy is the leading cause of end-stage renal disease, and both the incidence and prevalence of diabetic nephropathy continue to increase. Currently, various treatment regimens and combinations of therapies provide only partial renoprotection. It is obvious that new approaches are desperately needed to retard the progression of diabetic nephropathy. Recently, a number of new agents have been described that have the potential to delay the progression of diabetic kidney disease and… CONTINUE READING
29 Citations
75 References
Similar Papers


Publications citing this paper.
Showing 1-10 of 29 extracted citations


Publications referenced by this paper.
Showing 1-10 of 75 references

Bone morphoenetic protein2 antagonizes renal interstitial fibrosis by romoting catabolism of type I transforming growth factoreta receptors

  • YL Yang, YS Liu, LY Chuang
  • Endocrinology
  • 2009

TRC 4186 , a novel GEbreaker , improves diabetic cardiomyopathy and nehropathy in obZSF 1 model of type 2 diabetes

  • D Joshi, R Gupta, A Dubey
  • J Cardioasc Pharmacol
  • 2009

Similar Papers

Loading similar papers…